Enteric-coated mycophenolate sodium is effective and well-tolerated in patients with active lupus nephritis, Hong Kong researchers report. Investigators at Kwong Wah Hospital in Kowloon ...

Please provide your email address to receive an email when new articles are posted on . Tacrolimus alone had a dose-response relationship with achieving complete renal response in SLE. Combination ...

Early use of mycophenolate mofetil in at-risk patients with SLE reduced the risk of severe flare, potentially delaying lupus nephritis. Early application of mycophenolate mofetil may reduce the ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Despite new therapies and evolving research, lupus nephritis continues to present clinical and ...

Among patients with systemic lupus erythematosus (SLE) managed successfully with mycophenolate mofetil (MMF), rates of disease flare were not massively greater when the drug was withdrawn over several ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Brad Rovin, MD: ...

Lupkynis is a medicine that is used for a specific kidney disease called lupus nephritis. Lupus nephritis is a kidney condition that affects people with systemic lupus erythematosus (SLE). SLE is an ...

Doctors are reporting the first advance in three decades in treating kidney complications from lupus, a life-threatening disease that primarily affects young women. A small study showed that an immune ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. The ...